A perspective on new beta-lactam antibiotics in pediatric patients

Research output: Contribution to journalArticle

Abstract

With additional experience, it is likely that new cephalosporins will replace ampicillin and chloramphenicol as initial therapy for meningitis of infants and children. At present, the author prefers the combination of ampicillin and moxalactam or cefotaxime alone for infants from one to three months of age, when the etiologic bacteria are varied. The new cephalosporins are preferred therapy for the rare strains of H. influenzae resistant to ampicillin and chloramphenicol, and can be used in place of chloramphenicol in any situation in which there are clinical reasons to avoid use of chloramphenicol.

Original languageEnglish (US)
Pages (from-to)374-379
Number of pages6
JournalBulletin of the New York Academy of Medicine: Journal of Urban Health
Volume60
Issue number4
StatePublished - 1984

Fingerprint

beta-Lactams
Chloramphenicol
infant
Ampicillin
Pediatrics
Anti-Bacterial Agents
Cephalosporins
contagious disease
Moxalactam
Cefotaxime
present
Meningitis
Human Influenza
experience
Bacteria
Therapeutics

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

@article{5b9b4a12f90047adb1ac13e2e1a61cf6,
title = "A perspective on new beta-lactam antibiotics in pediatric patients",
abstract = "With additional experience, it is likely that new cephalosporins will replace ampicillin and chloramphenicol as initial therapy for meningitis of infants and children. At present, the author prefers the combination of ampicillin and moxalactam or cefotaxime alone for infants from one to three months of age, when the etiologic bacteria are varied. The new cephalosporins are preferred therapy for the rare strains of H. influenzae resistant to ampicillin and chloramphenicol, and can be used in place of chloramphenicol in any situation in which there are clinical reasons to avoid use of chloramphenicol.",
author = "Nelson, {J. D.}",
year = "1984",
language = "English (US)",
volume = "60",
pages = "374--379",
journal = "Journal of Urban Health",
issn = "1099-3460",
publisher = "Springer Science and Business Media Deutschland GmbH",
number = "4",

}

TY - JOUR

T1 - A perspective on new beta-lactam antibiotics in pediatric patients

AU - Nelson, J. D.

PY - 1984

Y1 - 1984

N2 - With additional experience, it is likely that new cephalosporins will replace ampicillin and chloramphenicol as initial therapy for meningitis of infants and children. At present, the author prefers the combination of ampicillin and moxalactam or cefotaxime alone for infants from one to three months of age, when the etiologic bacteria are varied. The new cephalosporins are preferred therapy for the rare strains of H. influenzae resistant to ampicillin and chloramphenicol, and can be used in place of chloramphenicol in any situation in which there are clinical reasons to avoid use of chloramphenicol.

AB - With additional experience, it is likely that new cephalosporins will replace ampicillin and chloramphenicol as initial therapy for meningitis of infants and children. At present, the author prefers the combination of ampicillin and moxalactam or cefotaxime alone for infants from one to three months of age, when the etiologic bacteria are varied. The new cephalosporins are preferred therapy for the rare strains of H. influenzae resistant to ampicillin and chloramphenicol, and can be used in place of chloramphenicol in any situation in which there are clinical reasons to avoid use of chloramphenicol.

UR - http://www.scopus.com/inward/record.url?scp=0021322905&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021322905&partnerID=8YFLogxK

M3 - Article

C2 - 6372913

AN - SCOPUS:0021322905

VL - 60

SP - 374

EP - 379

JO - Journal of Urban Health

JF - Journal of Urban Health

SN - 1099-3460

IS - 4

ER -